Programmable Biology: AI, Synthetic DNA, and the Future of Therapeutic Discovery
ABOUT THIS EVENT
- WHO IT IS FOR: Professionals and investors in biotechnology, synthetic biology, artificial intelligence, and venture capital.
- WHAT IT IS ABOUT: The intersection of AI, synthetic DNA, and the evolution of therapeutic discovery.
- FORMAT: An exclusive high-level gathering of industry leaders.
Discover the cutting edge of biotechnology at this exclusive gathering in Berkeley, California. This event brings together the brightest minds in AI and synthetic biology to discuss the future of programmable biology and its impact on therapeutic discovery.
Attendees will explore how the synergy between artificial intelligence and synthetic DNA is accelerating the development of next-generation medical treatments. Join a network of venture capitalists and biotech pioneers to discuss the trends shaping the future of medicine.
EXPLORE MORE